Eribulin is a synthetic macrocyclic ether compound used as a pharmaceutical intermediate in the manufacture of anticancer medications. It is a complex molecule containing multiple ether groups, an aromatic ring, and heterocyclic rings, with a high lipophilicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 253128-10-8
4,4,5,5-Tetramethyl-2-(3-methylphenyl)-1,3,2-dioxaborolane
chemical compound for research
25359-91-5
Industrial additive
3-Iodo-5-nitropyridin-2-ol
research reagent
1,4-Bis(1,2-dibromoethyl)benzene
Laboratory reagent
3-[(2S,5S)-5-[2-[(2S,4R,6R)-6-[[(2S,3S,4R,5R)-3-(benzenesulfonylmethyl)-5-[(2S)-2,3-bis[[tert-butyl(dimethyl)silyl]oxy]propyl]-4-methoxyoxolan-2-yl]methyl]-4-methyl-5-methylideneoxan-2-yl]ethyl]-4-methylideneoxolan-2-yl]propan-1-ol
PPPCYASYTNJMTF-VSRPWGLLSA-N
C[C@@H]1C[C@@H](O[C@@H](C1=C)C[C@H]2[C@@H]([C@H]([C@H](O2)C[C@@H](CO[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)OC)CS(=O)(=O)C3=CC=CC=C3)CC[C@H]4C(=C)C[C@@H](O4)CCCO
—